HK Stock Market Move | JST GROUP (06687) Soars 20% in the Afternoon, Reaching a New High on the Stock Market. The company is a leading provider of e-commerce SaaS solutions with a significant market share.
Ju Shuitan (06687) soared 20% in the afternoon, reaching a high of 41.72 Hong Kong dollars, hitting a new high since listing, rising more than 36% from the offer price of 30.6 Hong Kong dollars. As of the time of publication, it rose 3.29% to 35.2 Hong Kong dollars, with a turnover of 277 million Hong Kong dollars.
JST GROUP (06687) soared 20% in the afternoon, reaching a high of 41.72 Hong Kong dollars, hitting a new high since its IPO at 30.6 Hong Kong dollars, up more than 36%. As of the time of writing, it had risen by 3.29%, to 35.2 Hong Kong dollars, with a trading volume of 2.77 billion Hong Kong dollars.
Public information shows that JST GROUP is a leading Chinese e-commerce SaaS solution provider, with its core business focusing on the digital operation needs of e-commerce merchants. With cloud-native SaaS products at its core, it provides one-stop business monitoring, operation, and management services for e-commerce merchants of different types and sizes, helping them achieve efficient cross-platform collaboration and data-driven decision-making.
According to data from Zhushi Consulting, as of 2024, in terms of relevant revenue, the company holds a 24.4% market share in the field of e-commerce SaaS ERP in China, making it the largest provider in the industry. This market share exceeds the combined total of the second to fifth largest participants, and its core product "JST GROUP ERP" has been rated as the most popular e-commerce SaaS ERP brand among Chinese merchants, forming a strong barrier to entry in the core business operations tool race. In the Chinese e-commerce operation SaaS market, the company ranks first in terms of total SaaS revenue in 2024, with a market share of 8.7%, covering the full range of merchants' operational needs, including ERP, CRM, sales and marketing management, leading in terms of business coverage breadth.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276): Injection of \(derived\) single-antibody \(drug\) approved to conduct clinical trials.

Northbound funds | Northbound trading volume reached a net buying of 5.345 billion yuan, with Europe and America adding sanctions on Russian oil. Northbound trading also increased its position in CNOOC (00883) by nearly 1 billion Hong Kong dollars.

YAN PALACE (01497) spent 810,000 Hong Kong dollars to repurchase 100,000 shares on October 23rd.
Jiangsu Hengrui Pharmaceuticals (01276): Injection of \(derived\) single-antibody \(drug\) approved to conduct clinical trials.

Northbound funds | Northbound trading volume reached a net buying of 5.345 billion yuan, with Europe and America adding sanctions on Russian oil. Northbound trading also increased its position in CNOOC (00883) by nearly 1 billion Hong Kong dollars.

YAN PALACE (01497) spent 810,000 Hong Kong dollars to repurchase 100,000 shares on October 23rd.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025